Plasmid DNA CDMOs — Ranked by Signal Score · 2026
Plasmid DNA manufacturers on CDMO Signal: 22 listed, 22 with a Signal Score. Together they have 65 FDA inspections on file (including 26 NAI, 37 VAI and 2 OAI), 2 FDA warning letters and 117 EMA/MHRA GMP certificates. Fewer than three are fully evidenced (all four score pillars and at least one ClinicalTrials.gov match), so this page does not name a top three. Signal Score is computed from FDA inspection records, EMA EudraGMDP and MHRA GMP certificates, and ClinicalTrials.gov. CDMOs cannot pay to change it. Updated 2026-11-20. Methodology.
Plasmid DNA CDMOs with the most regulatory evidence on file
Shortlist plasmid DNA CDMOs with Signal
CDMO Signal is an independent sourcing platform cell therapy, gene therapy, and mRNA sponsors use to compare and shortlist plasmid DNA CDMOs before an RFI. This page is the entry point — the ranked table below is derived from FDA inspection history, EMA/MHRA GMP certificate density, ClinicalTrials.gov sponsor and program footprint, and monitored capacity signals. Use it to narrow the field, then verify fermentation scale, purity specifications, endotoxin control, and lead time directly with the shortlisted suppliers — especially when plasmid is on your program's critical path for viral vector or mRNA supply.
- Compare plasmid DNA CDMOs side-by-side on FDA inspection history, EMA/MHRA GMP certificate density, ClinicalTrials.gov sponsor and program footprint, and monitored capacity signals — every number traceable to primary sources.
- Filter by regulatory jurisdiction, clean-inspection posture, and clinical-program breadth to your program's shortlisting criteria.
- Shortlist Use the ranked results to build your shortlist, then open each profile to review the underlying evidence before contacting suppliers. Follow up with the shortlisted CDMOs to verify fermentation scale, purity specifications, endotoxin control, and lead time directly.
Plasmid DNA is the upstream starting material for viral vectors, mRNA, and DNA therapeutics — which makes plasmid supply a frequent bottleneck for the entire advanced-therapy pipeline. Plasmid CDMOs run microbial (E. coli) fermentation, alkaline lysis, and chromatographic purification to GMP grade.
Selecting a plasmid CDMO turns on GMP vs research grade, supercoiled fraction and purity, fermentation scale, and lead time. The rankings below score each CDMO on FDA inspections, GMP certification, clinical activity, and capacity.
FDA inspection outcomes across these CDMOs: 26 NAI (no action), 37 VAI (voluntary action), 2 OAI (official action). Leading inspection & GMP sites: United States (50), UNITED KINGDOM (34), Germany (30), Belgium (12), Austria (12).
Last updated 2026-11-20. Sourced from FDA, EMA EudraGMDP, MHRA GMDP, and ClinicalTrials.gov.
Ranked by Signal Score (0–100). Fully evidenced marks a CDMO scored on all four pillars with at least one confirmed clinical program. Partly scored and profile-only CDMOs follow the scored rows. How we score
Showing all operator types.
| # | CDMO | Signal Score | Quality | FDA · GMP | Last FDA inspection | Capacity | Programs |
|---|---|---|---|---|---|---|---|
| 1 |
PB
San Diego, CA · Shaoxing, China, Liverpool, UK, Ningbo China
|
86.9 | 100.0 | 5 insp · 1 GMP | 2026-08-14 · NAI | Available | — |
| 2 |
CR
Newbury Park, CA · Memphis, TN · Keele, UK · Rockville, MD
|
86.3 | 99.2 | 9 insp · 11 GMP | 2026-05-01 · NAI | Limited | — |
| 3 |
KB
|
84.1 | 98.5 | 2 insp · 1 GMP | 2026-04-01 · VAI | Limited | — |
| 4 |
RP
Keele, UK · Sodertalje, SE
|
82.9 | 100.0 | 0 insp · 3 GMP | None on file | — | — |
| 5 |
WK
Jena, DE · Amsterdam, NL · San Diego, CA
|
82.9 | 100.0 | 1 insp · 13 GMP | 2023-12-07 · VAI | — | — |
| 6 |
RB
Hamburg, Germany
|
82.9 | 100.0 | 0 insp · 9 GMP | None on file | — | — |
| 7 |
KE
Seraing, BE
|
81.6 | 99.9 | 1 insp · 4 GMP | 2024-02-26 · VAI | — | — |
| 8 |
AE
|
80.3 | 100.0 | 1 insp · 0 GMP | 2024-11-08 · NAI | — | — |
| 9 |
Oklahoma City, OK
|
78.6 | 98.2 | 1 insp · 0 GMP | 2026-06-17 · VAI | Available | — |
| 10 |
AA
Rockville, MD · Alachua, FL · Munich, DE
|
78.1 | 100.0 | 0 insp · 1 GMP | None on file | — | — |
| 11 |
TF
Plainville, MA · Alachua, FL · Cambridge, MA
Hiring · 299 open roles
Fully evidenced
|
77.6 | 93.2 | 19 insp · 10 GMP | 2026-06-30 · NAI | Available | 2 programs |
| 12 |
BM
Vienna, Austria
|
76.8 | 100.0 | 0 insp · 12 GMP | None on file | — | — |
| 13 |
OX
Oxford, United Kingdom
Hiring · 4 open roles
Fully evidenced
Also makes its own products
|
76.2 | 100.0 | 2 insp · 13 GMP | 2024-06-17 · NAI | Available | 7 programs |
| 14 |
|
76.1 | 77.3 | 24 insp · 39 GMP | 2026-05-22 · VAI Warning letter 2025-11-20 |
— | — |
| 15 |
VE
Rockville, MD · Memphis, TN · Keele, United Kingdom
|
64.0 | — | — | None on file | — | — |
| 16 |
AN
Columbus, OH
|
63.0 | — | — | None on file | Available | — |
| 17 |
BN
Fremont, CA
|
59.0 | — | — | None on file | — | — |
| 18 |
HX
|
59.0 | — | — | None on file | — | — |
| 19 |
UB
|
56.5 | — | — | None on file | — | — |
| 20 |
NE
Lincoln, NE
|
56.5 | — | — | None on file | — | — |
| 21 |
VX
The Woodlands, TX
|
56.5 | — | — | None on file | — | — |
| 22 |
PF
Bielefeld, Germany
|
56.5 | — | — | None on file | — | — |